148 related articles for article (PubMed ID: 1695606)
1. Normal B cell compartment in chronic lymphatic leukemia.
Pluta A; Górski A; Nowaczyk M; Modlińska M
Hematol Oncol; 1990; 8(3):121-4. PubMed ID: 1695606
[TBL] [Abstract][Full Text] [Related]
2. CD20 and CD5 expression in B-chronic lymphocytic leukemia.
Marti GE; Faguet G; Bertin P; Agee J; Washington G; Ruiz S; Carter P; Zenger V; Vogt R; Noguchi P
Ann N Y Acad Sci; 1992 May; 651():480-3. PubMed ID: 1376065
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia.
Almasri NM; Duque RE; Iturraspe J; Everett E; Braylan RC
Am J Hematol; 1992 Aug; 40(4):259-63. PubMed ID: 1380203
[TBL] [Abstract][Full Text] [Related]
4. [Cell membrane characteristics of B-lymphocytes in chronic lymphocytic leukemia. II. Expression of B-cell markers].
Pluta A; Górski A; Nowaczyk M
Pol Arch Med Wewn; 1991 Sep; 86(3):154-8. PubMed ID: 1725559
[TBL] [Abstract][Full Text] [Related]
5. The B-cells that express anti-MAG antibodies in neuropathy and non-malignant IgM monoclonal gammopathy belong to the CD5 subpopulation.
Lee KW; Inghirami G; Spatz L; Knowles DM; Latov N
J Neuroimmunol; 1991 Jan; 31(1):83-8. PubMed ID: 1701449
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of CD11c+CD5+ chronic B-cell leukemias and the identification of novel peripheral blood B-cell subsets with chronic lymphoid leukemia immunophenotypes.
Wormsley SB; Baird SM; Gadol N; Rai KR; Sobol RE
Blood; 1990 Jul; 76(1):123-30. PubMed ID: 1694698
[TBL] [Abstract][Full Text] [Related]
7. CD11c (LEU-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia.
Hanson CA; Gribbin TE; Schnitzer B; Schlegelmilch JA; Mitchell BS; Stoolman LM
Blood; 1990 Dec; 76(11):2360-7. PubMed ID: 1701669
[TBL] [Abstract][Full Text] [Related]
8. Association of bone marrow growth pattern, coexpression of CD14, and B-cell CD5 antigen density in 45 B-chronic lymphocytic leukemia (B-CLL) patients.
Paglieroni T; Caggiano V; MacKenzie MR
Ann N Y Acad Sci; 1992 May; 651():484-5. PubMed ID: 1376066
[No Abstract] [Full Text] [Related]
9. Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements.
Vuillier F; Claisse JF; Vandenvelde C; Travade P; Magnac C; Chevret S; Desablens B; Binet JL; Dighiero G
Leuk Lymphoma; 1992 Jun; 7(3):195-204. PubMed ID: 1282428
[TBL] [Abstract][Full Text] [Related]
10. 2D-gel analysis of proteins in chronic lymphocytic leukemia cells and normal B-lymphocytes.
Saunders FK; Sharrard RM; Winfield DA; Lawry J; Goepel JR; Hancock BW; Goyns MH
Leuk Res; 1993 Mar; 17(3):223-30. PubMed ID: 7680735
[TBL] [Abstract][Full Text] [Related]
11. [Membrane characteristics of pathological clones of B-lymphocytes in patients with chronic lymphocytes leukemia (CLL)].
Pluta A
Pol Arch Med Wewn; 1989; 82(4-6):195-201. PubMed ID: 2642224
[No Abstract] [Full Text] [Related]
12. CD5+, CD11c+, CD20+ hairy cell leukemia.
Heimann PS; Vardiman JW; Stock W; Platanias LC; Golomb HM
Blood; 1991 Apr; 77(7):1617-9. PubMed ID: 1706957
[No Abstract] [Full Text] [Related]
13. Proliferative response of highly purified B chronic lymphocytic leukemia cells in serum free culture to interleukin-2 and tumor necrosis factors alpha and beta.
Moberts R; Hoogerbrugge H; van Agthoven T; Löwenberg B; Touw I
Leuk Res; 1989; 13(11):973-80. PubMed ID: 2481793
[TBL] [Abstract][Full Text] [Related]
14. Detection of trisomy 12 by FISH in untreated B-chronic lymphocytic leukemia: correlation with stage and CD20 antigen expression intensity.
Witzig TE; Borell TJ; Herath JF; Tefferi A; Li CY; Jenkins RB
Leuk Lymphoma; 1994 Aug; 14(5-6):447-51. PubMed ID: 7529078
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the expression of critical activation/interaction markers on peripheral blood T cells in B-cell chronic lymphocytic leukaemia: evidence of immune dysregulation.
Scrivener S; Kaminski ER; Demaine A; Prentice AG
Br J Haematol; 2001 Mar; 112(4):959-64. PubMed ID: 11298591
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia.
Gagro A; Dasić G; Sabioncello A; Rabatić S; Reckzeh B; Havemann K; Kardum I; Jacksić B; Vitale B
Leuk Lymphoma; 1997 Apr; 25(3-4):301-11. PubMed ID: 9168440
[TBL] [Abstract][Full Text] [Related]
17. The utility of CD20 and CD43 in subclassification of low-grade B-cell lymphoma on paraffin sections.
Contos MJ; Kornstein MJ; Innes DJ; Ben-Ezra J
Mod Pathol; 1992 Nov; 5(6):631-3. PubMed ID: 1285443
[TBL] [Abstract][Full Text] [Related]
18. IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewing.
Wakai M; Hashimoto S; Omata M; Sthoeger ZM; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Diamond B; Dono M
Autoimmunity; 1994; 19(1):39-48. PubMed ID: 7538331
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotyping of subtypes of B-chronic (mature) lymphoid leukemia. A study of 242 cases.
Batata A; Shen B
Cancer; 1992 Nov; 70(10):2436-43. PubMed ID: 1384948
[TBL] [Abstract][Full Text] [Related]
20. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
Hashimoto S; Dono M; Wakai M; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Ferrarini M; Silver J; Chiorazzi N
J Exp Med; 1995 Apr; 181(4):1507-17. PubMed ID: 7535340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
